Concepedia

Aaron M. D’Antona

AM

Statistics

Publications

19

Citations

1.3K

H-Index

16

Active since

1965

Affiliations

Pfizer (United States)(Current)

Brandeis University

University of Connecticut

Paul Scherrer Institute

MRC Laboratory of Molecular Biology

Aaron M. D’Antona is an author at Pfizer (United States) specializing in life sciences, biochemistry, and protein engineering.

ORCID

Publications per year

1965–2023

19

Publications

19

The structural basis of agonist-induced activation in constitutively active rhodopsin

Jörg Standfuss, Patricia C. Edwards, Aaron M. D’Antona et al. · Nature · 2011 · 470 citations

, , +13

Oleamide is a selective endogenous agonist of rat and human CB<sub>1</sub> cannabinoid receptors

James D. Leggett, Sue Aspley, Simon Beckett et al. · British Journal of Pharmacology · 2004 · 173 citations · Full text

, , +11

Membrane Assembly of the Cannabinoid Receptor 1: Impact of a Long N-Terminal Tail

Helena Andersson, Aaron M. D’Antona, Debra A. Kendall et al. · Molecular Pharmacology · 2003 · 123 citations

, , +13

Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer

Wei Cao, Bilian Li, Peter LaPan et al. · Antibodies · 2016 · 95 citations · Full text

, , +17

Mutations of CB<sub>1</sub> T210 Produce Active and Inactive Receptor Forms:  Correlations with Ligand Affinity, Receptor Stability, and Cellular Localization

Aaron M. D’Antona, Kwang H. Ahn, Debra A. Kendall · Biochemistry · 2006 · 58 citations · Full text

, , +17

1–5 of 19